| Financial Year |
March 31 2023 |
| Monetary Funds |
349,644,313.93 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
3,100,000.00 |
| Accounts Receivable |
133,940,495.15 |
| Advances to Suppliers |
89,160,290.28 |
| Other Receivables |
28,960,522.26 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
940,665,117.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
37,781,614.81 |
| Total Current Assets |
1,586,826,854.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
28,172,679.90 |
| Fixed Assetes |
224,622,130.66 |
| Under-construction Projects |
10,475,906.55 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
72,037,423.52 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,334,572.03 |
| Deferred Income Tax Assets |
36,428,625.18 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
401,041,857.98 |
| Total Assets |
1,987,868,712.76 |
| Short-Term Loans |
144,145,390.35 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
234,684,805.97 |
| Accounts Received In Advance |
4,107,313.40 |
| Employee Compensation Payable |
25,123,877.88 |
| Taxes Payable |
8,358,843.26 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
27,092,534.54 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,422,556.03 |
| Other Current Liabilities |
49,615,032.33 |
| Sub-Total of Current Liabilities |
1,051,192,237.47 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,598,966.60 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
132,045,569.01 |
| Total Liabilities |
1,183,237,806.48 |
| Paid-In Capital(Or Share Stock) |
121,342,000.00 |
| Capital Surplus |
178,467,015.20 |
| Surplus Reserve |
53,032,947.90 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
432,000,537.18 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
804,630,906.28 |
| Owner's Equity（Stockholder's Equity） |
804,630,906.28 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,987,868,712.76 |
